A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 252 participants.
Also called NCT07654140
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 252 participants
- Registry
-
NCT07654140
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07654140. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-09 (actual); primary completion 2027-03-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension
- Condition
- Uncontrolled Hypertension
- Intervention (Drug)
- SAL0140
- Intervention (Drug)
- SAL0140
- Intervention (Drug)
- SAL0140
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
Record details
- Record id
cardio:ct-nct07654140- Content hash
ff21ee016ac1cdededc39f71f1b5031e4404bac0089ebc9225fb183f05d30fe9